Ted W. Love
2018
In 2018, Ted W. Love earned a total compensation of $10.3M as President, Chief Executive Officer and Director at Global Blood Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $414,000 |
|---|---|
| Option Awards | $4,623,690 |
| Salary | $568,750 |
| Stock Awards | $4,648,800 |
| Other | $5,000 |
| Total | $10,260,240 |
Love received $4.6M in stock awards, accounting for 45% of the total pay in 2018.
Love also received $414K in non-equity incentive plan, $4.6M in option awards, $568.8K in salary and $5K in other compensation.
Rankings
In 2018, Ted W. Love's compensation ranked 656th out of 14,244 executives tracked by ExecPay. In other words, Love earned more than 95.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 656 out of 14,244 | 95th |
Division Manufacturing | 215 out of 5,759 | 96th |
Major group Chemicals And Allied Products | 59 out of 2,122 | 97th |
Industry group Drugs | 45 out of 1,811 | 98th |
Industry Pharmaceutical Preparations | 32 out of 1,385 | 98th |
Source: SEC filing on April 28, 2021.
Love's colleagues
We found four more compensation records of executives who worked with Ted W. Love at Global Blood Therapeutics in 2018.